ADVFN - Advanced Financial Network.
HOME» NASDAQ » M » MDVN Stock Price » MDVN Stock News

Medivation Share News

 Medivation (mm) Stock Price
MDVN Stock Price
 Medivation (mm) Stock Chart
MDVN Stock Chart
 Medivation (mm) Stock News
MDVN Stock News
 Medivation (mm) Company Information
MDVN Company Information
 Medivation (mm) Stock Trades
MDVN Stock Trades

MARKET SNAPSHOT: U.S. Stocks Gain On Jobs, Services Prospects

By Kristina Peterson The materials sector led U.S. stocks higher Wednesday as better-than-expected reports on private-sector jobs and the services sector in the U.S. provided a boost, while new budget-stabilizing plans from Greece weighed on the U.S. dollar. The Dow Jones Industrial Average (DJI) was up 22 points, or 0.2%, at 10,427, making its year-to-date performance nearly unchanged. The index on Tuesday crossed into positive territory for the year for the first time since January, but wasn't able to hold it into the close. Headlining Wednesday's economic news, payroll giant Automatic Data Processing reported a fewer-than-expected private-sector job losses. Also boosting sentiment, the Institute for Supply Management said U.S. non-manufacturing sector expanded at a faster-than-expected pace in February, although employment within the broad sector was still contracting. "It does look like we're at a modest growth," said Ben Halliburton, chief investment officer at Tradition Capital Management, though he was disappointed with the employment portion of ISM's report. "It's hard to have a self-sustaining recovery when employment's very difficult." The Nasdaq Composite (RIXF) rose 0.2%. The Standard & Poor's 500-stock (SPX) index advanced 0.3%, led by its materials sector. The health-care sector was the S&P 500's only category in the red, declining ahead of remarks President Barack Obama was set to make laying out his strategy for bringing the long-running debate over health care to a conclusion. "Anything that increases the odds that a deal could be struck, which is what Obama's proposals do, is going to hurt the health-care stocks," said Jim McDonald, chief investment strategist at Northern Trust Global Investments. "They're facing a headwind now with the re-focus on getting a bill passed through." Supporting commodities stocks, the dollar fell against the euro after the Greek government announced a new austerity plan Wednesday totaling 4.8 billion ($6.53 billion) to ensure it can meet its deficit-cutting pledge this year, including steep cuts in civil service salaries and entitlements. Greece will also raise its sales tax by two percentage points. Crude-oil prices climbed above $80 a barrel and gold futures rose . Treasurys declined, with the 10-year note off 6/32 to yield 3.631%. Movers Industrial giant Caterpillar Inc. (CAT) rose 1.7%, helping the Dow climb, as the economically sensitive company was boosted by the latest round of improving data points. General Electric Co. (GE) rose 1.5%, boosted by the signs of economic growth, along with materials components Alcoa Inc. (AA) and DuPont (DD). Alcoa rose 1.7% and DuPont climbed 1.1%. The Dow was also bolstered by its financial components as Fitch Ratings said U.S. credit card delinquencies declined in the January collection period, though charge-offs spiked. Drug maker Pfizer (PFE) was the Dow's worst component. The stock shed 1.6% after Medivation said its experimental Alzheimer's disease treatment Dimebon, which was in development with Pfizer, failed to show effectiveness in a large late-stage study. The news sent shares of Medivation (MDVN) -- which has no products on the market and isn't a Dow component -- plunging 67% on heavy volume. Novell (NOVL) shares surged 27% to $6.01, topping an offer price announced late Tuesday from hedge fund Elliott Associates and sparking speculation another software company or hedge fund could step in with a higher bid.

Stock News for Medivation (MDVN)
03/24/201507:23:00Astellas Announces New Enzalutamide Data Presented During Plenary...
03/22/201507:01:07Best One-Drug Wonder Stock for 2015
03/19/201508:00:00New Enzalutamide Data to Be Presented in Late Breaking News Plenary...
03/17/201517:38:26Statement of Changes in Beneficial Ownership (4)
03/16/201516:10:00New Enzalutamide Data To Be Presented In Late Breaking News Plenary...
03/09/201518:14:32Johnson & Johnson Might Have The Last Laugh Over AbbVie Winning...
03/09/201507:21:08Insider Insider Buys And Sells: Twitter, Graham Holdings
03/03/201507:00:00Will Medivation Kick J&J To The Curb For This $9 Billion Market?
02/28/201513:56:43Pharmacyclics: Is A $19 Billion Valuation Reasonable?
02/27/201517:53:43Statement of Changes in Beneficial Ownership (4)
02/25/201523:40:12Medivation's (MDVN) CEO David Hung on Q4 2014 Results - Earnings...
02/18/201517:59:40Statement of Changes in Beneficial Ownership (4)
02/18/201517:57:34Statement of Changes in Beneficial Ownership (4)
02/18/201517:56:11Statement of Changes in Beneficial Ownership (4)
02/18/201517:55:20Statement of Changes in Beneficial Ownership (4)
02/17/201514:48:30Amended Statement of Ownership (sc 13g/a)
02/13/201510:28:36Amended Statement of Ownership (sc 13g/a)
02/12/201516:22:33Statement of Changes in Beneficial Ownership (4)
02/11/201517:02:41Statement of Changes in Beneficial Ownership (4)
02/11/201517:01:44Statement of Changes in Beneficial Ownership (4)

Medivation and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations